Northwest Biotherapeutics Statistics

Total Valuation

BST:NBYB has a market cap or net worth of EUR 311.78 million. The enterprise value is 380.54 million.

Market Cap	311.78M
Enterprise Value	380.54M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.48B
Shares Outstanding	n/a
Shares Change (YoY)	+11.99%
Shares Change (QoQ)	+3.97%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.35B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	228.78
PB Ratio	-3.97
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.79
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.49

Financial Position

The company has a current ratio of 0.06

Current Ratio	0.06
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.26
Interest Coverage	-8.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-151.76%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	122.54%
Revenue Per Employee	54,513
Profits Per Employee	-3.18M
Employee Count	25
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-40.22%
50-Day Moving Average	0.24
200-Day Moving Average	0.25
Relative Strength Index (RSI)	48.94
Average Volume (20 Days)	11,991

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	12.77

Income Statement

In the last 12 months, BST:NBYB had revenue of EUR 1.36 million and -79.49 million in losses. Loss per share was -0.06.

Revenue	1.36M
Gross Profit	-31.29M
Operating Income	-62.98M
Pretax Income	-78.47M
Net Income	-79.49M
EBITDA	-61.36M
EBIT	-62.98M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 2.57 million in cash and 63.84 million in debt, giving a net cash position of -61.27 million.

Cash & Cash Equivalents	2.57M
Total Debt	63.84M
Net Cash	-61.27M
Net Cash Per Share	n/a
Equity (Book Value)	-78.49M
Book Value Per Share	-0.07
Working Capital	-72.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -49.99 million and capital expenditures -803,074, giving a free cash flow of -50.79 million.

Operating Cash Flow	-49.99M
Capital Expenditures	-803,074
Free Cash Flow	-50.79M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-4,621.52%
Pretax Margin	-5,757.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BST:NBYB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.99%
Shareholder Yield	-11.99%
Earnings Yield	-25.50%
FCF Yield	-16.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:NBYB has an Altman Z-Score of -83.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-83.67
Piotroski F-Score	2